Cholesterol crystals in a gout tophus

QR Code

Cholesterol crystals in a gout tophus

Saved in:

Bibliographic Details
Main Authors:	M S Eliseev, M M Saharova, A A Fedorova, V G Barskova, V A Nasonova
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2007-10-01
Series:	Научно-практическая ревматология
Online Access:	https://rsp.mediar-press.net/rsp/article/view/310
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Actovegin administration in patients with ulcerated gout tophuses
by: M S Eliseev, et al.
Published: (2005-10-01)

GOUT WITH TOPHUS MIMICKING A TUMOR OF THE THORACIC SPINE
by: V. N. Sorotskaya, et al.
Published: (2018-03-01)

GOUT OUTCOMES. A REVIEW OF LITERATURE. PART 1. GOUT: EPIDEMIOLOGY, RISK FACTORS, COURSE OF THE DISEASE WITH THE DEVELOPMENT OF CHRONIC TOPHUS FORM
by: Igor Sergeyevich Denisov, et al.
Published: (2013-12-01)

Alcohol and the clinical picture of gout
by: V G Barskova, et al.
Published: (2007-09-01)

Impact of age on the frequency and magnitude of the signs of metabolic syndrome in patients with gout
by: V A Nasonova, et al.
Published: (2007-09-01)

MULTIMODALITY THERAPY FOR CHRONIC TOPHACEOUS GOUT
by: M S Eliseev, et al.
Published: (2008-12-01)

Use of Blemaren citrate formula in gout patients with nephrolithiasis
by: M S Eliseev, et al.
Published: (2008-09-01)

CLINICAL FEATURES OF GOUT IN WOMEN: THE RESULTS OF A COMPARATIVE STUDY
by: M. S. Eliseev, et al.
Published: (2014-06-01)

GOUT OUTCOMES. LITERATURE REVIEW. PART II. COMORBID DISEASES, RISK OF DEVELOPING CARDIOVASCULAR CATASTROPHES AND DEATH IN GOUT PATIENTS
by: Igor Sergeevich Denisov, et al.
Published: (2014-02-01)

Use of citrate formulas in patients with gout and nephrolithiasis
by: F M Kudaeva, et al.
Published: (2007-09-01)

Short course of glucocorticoids in patients with protracted and chronic gout arthritis. Part I: predictors of therapy efficacy
by: A A Fedorova, et al.
Published: (2008-06-01)

A case of successful treatment for chronic tophaceous gout
by: E L Nasonov, et al.
Published: (2007-09-01)

Administration of chondroprotector piascledine in the treatment of secondary osteoarthritis in patients with gout
by: M. S. Eliseev, et al.
Published: (2016-05-01)

Short term administration of glucocorticoids in patients with protracted and chronic gout arthritis. Part III – frequency of adverse events
by: A A Fedorova, et al.
Published: (2009-04-01)

Short-term glucocorticoid administration in patients with protracted and chronic gout arthritis. Part 2 — comparison of different medication forms efficacy
by: A A Fedorova, et al.
Published: (2008-10-01)

Rational approaches to treating gout
by: V G Barskova, et al.
Published: (2008-03-01)

Diagnosis of gout (a lecture)
by: V G Barskova
Published: (2012-08-01)

Use of urisan in gout
by: A E Il'ina, et al.
Published: (2008-03-01)

ATYPICAL GOUT: SPINAL TOPHACEOUS INJURY
by: Maksim Sergeevich Eliseev, et al.
Published: (2013-12-01)

Comparison of speed of anti-inflammatory and analgesic effect appearance of nimesulid and diclofenac sodium tablets in gout arthritis: a randomized study
by: F. M. Kudaeva, et al.
Published: (2008-02-01)

DIET IN GOUT AND HYPERURICEMIA
by: O. V. Zhelyabina, et al.
Published: (2017-09-01)

The place of febuxostat in the treatment of gout
by: A. M. Novikova, et al.
Published: (2020-09-01)

SIGNIFICANCE OF DIET AND DIETARY SUPPLEMENTS IN GOUT
by: A E Il'ina, et al.
Published: (2008-12-01)

Therapy with canakinumab for gout
by: M. S. Eliseev, et al.
Published: (2019-04-01)

Cholesterol crystal embolization induced kidney disease
by: Shohan Pervaze, et al.
Published: (2025-08-01)

Canakinumab (an interleukin 1β inhibitor) is a breakthrough in the possibilities of anti-inflammatory therapy for gout
by: Maksim Sergeevich Eliseev, et al.
Published: (2013-11-01)

Gout, hyperuricemia and cardiovascular risk
by: A E Iljina, et al.
Published: (2009-02-01)

Type 2 diabetes mellitus and gout
by: O. V. Zhelyabina, et al.
Published: (2021-10-01)

NEW INTERNATIONAL RECOMMENDATIONS FOR THE DIAGNOSIS AND TREATMENT OF GOUT
by: M. S. Eliseev
Published: (2014-06-01)

GOUT CLASSIFICATION CRITERIA (ACR/EULAR GUIDELINES)
by: M. S. Eliseev
Published: (2016-02-01)

Glomerular filtration rate in patients with gout and factors influencing the rate
by: F M Kudaeva, et al.
Published: (2007-09-01)

Rational approaches to diagnosing gout (according to the European Antirheumatic League Guidelines)
by: V G Barskova, et al.
Published: (2007-09-01)

Gout in history of humanity
by: M. S. Eliseev, et al.
Published: (2024-06-01)

Prevalence and risk f actors influencing the development of arterial hypertension in patients with a gout
by: E. I. Markelova, et al.
Published: (2021-01-01)

Sacroiliitis in gout: Difficulties of diagnosis
by: E. M. Agafonova, et al.
Published: (2024-01-01)

Febuxostat in the therapy of gout: from theory to practice
by: E. V. Ilyinykh, et al.
Published: (2018-01-01)

Losartan therapy in gout patients
by: A. I. Ilyina, et al.
Published: (2008-04-01)

Febuxostat is a novel drug in therapy for gout
by: V G Barskova, et al.
Published: (2011-04-01)

Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota
by: M. S. Eliseev, et al.
Published: (2022-12-01)

Experience with canakinumab in a patient with gout and IgA nephropathy
by: E. V. Ilyinykh, et al.
Published: (2019-09-01)